Three antipsychotic drugs appear to work in children and teens but their risks must be weighed as the makers aim to promote the medicines for youth, U.S. drug reviewers said in documents released on Friday.The Food and Drug Administration is considering whether to approve AstraZeneca's Seroquel, Pfizer's Geodon and Eli Lilly and Co's Zyprexa for children and teens with schizophrenia or bipolar disorder. All three are blockbuster medicines already sold for adults.
An FDA panel meets next week to make recommendations on the companies' bids to promote the drugs for children and teens.
Read more...
No comments:
Post a Comment
Thanks for your comment it is much appreciated.